It is conceivable that variants in the CTNND2 gene may play a role in the dysregulation of endothelial progenitor cells observed in vasculopathic complications of SSc, such as pulmonary arterial hypertension and scleroderma renal crisis [98]. This evidence concerns the gene CTNND2 and systemic sclerosis.